Gu Junxiang, Jiang Tingting, Liu Shixue, Ping Bo, Li Ruiwen, Chen Wenwen, Wang Ling, Huang Xin, Xu Gezhi, Chang Qing
Department of Ophthalmology, Eye and ENT Hospital of Fudan University, Fudan University, Shanghai, China.
Shanghai Key Laboratory of Visual Impairment and Restoration, Eye and ENT Hospital of Fudan University, Fudan University, Shanghai, China.
Front Oncol. 2022 Jul 19;12:932674. doi: 10.3389/fonc.2022.932674. eCollection 2022.
To seek novel diagnostic approaches, we improved the workflow of cell-free DNA (cfDNA) sequencing and evaluated its feasibility in vitreoretinal lymphoma (VRL) specimens; the profile of mutations was preliminarily analyzed for potential diagnostic value.
The study was a diagnostic trial. 23 eyes of 23 patients with VRL and 25 eyes of 25 patients with inflammatory eye diseases were enrolled. Approximate 500μl undiluted vitreous humor and 10ml diluted vitreous fluid was obtained through diagnostic vitrectomy and sent for cytopathological examinations. 500μl of the diluted vitreous fluid was spared for cfDNA sequencing. For cfDNA sequencing, DNA fragmentation procedure was added to the workflow to improve the extraction efficiency; mutations detected were analyzed for potential diagnostic model. The sensitivity and specificity of the cytopathology and cfDNA sequencing were compared. The clinical manifestations were preliminarily analyzed for potential correlations with the genotypes.
CfDNA sequencing was accomplished in 23 eyes with VRL and 20 eyes with inflammatory eye diseases. VRL-related mutated genes included (18 eyes, 78%), (11 eyes, 48%), (11 eyes,48%), (7 eyes, 30%), (7 eyes, 30%), (6 eyes, 26%), (6 eyes, 26%), etc. Logistic regression based on the mutations of and was of the potential for the diagnosis of VRL (P<0.001, adjusted R2 = 0.789, sensitivity 0.913, specificity 0.950); by comparison, the sensitivity and specificity of the vitreous cytopathology were 0.826 and 1.000, respectively. Further analysis of the mutation profile showed that patients carrying mutation tended to have higher intraocular interleukin-10 level (P=0.030), that CARD11 mutation was correlated with younger age at ocular onset (P=0.039), and that patients with intracranial involvement carried more multiple-site mutations in the gene (P=0.013).
The improved workflow of CfDNA sequencing is of sound feasibility in a limited amount of vitreous humor. The logistic model based on the mutations could help to provide reliable clues for the diagnosis of VRL.
为寻找新的诊断方法,我们改进了游离DNA(cfDNA)测序流程,并评估其在玻璃体视网膜淋巴瘤(VRL)标本中的可行性;初步分析突变谱以探讨其潜在诊断价值。
本研究为诊断性试验。纳入23例VRL患者的23只眼以及25例炎性眼病患者的25只眼。通过诊断性玻璃体切割术获取约500μl未稀释的玻璃体液和10ml稀释的玻璃体液,送去做细胞病理学检查。留取500μl稀释的玻璃体液用于cfDNA测序。对于cfDNA测序,在流程中增加DNA片段化步骤以提高提取效率;对检测到的突变进行分析以建立潜在诊断模型。比较细胞病理学和cfDNA测序的敏感性和特异性。初步分析临床表现与基因型之间的潜在相关性。
23例VRL患者的23只眼以及20例炎性眼病患者的20只眼完成了cfDNA测序。与VRL相关的突变基因包括(18只眼,78%)、(11只眼,48%)、(11只眼,48%)、(7只眼,30%)、(7只眼,30%)、(6只眼,26%)、(6只眼,26%)等。基于和突变的逻辑回归模型对VRL诊断具有潜在价值(P<0.001,调整后R2 = 0.789,敏感性0.913,特异性0.950);相比之下,玻璃体细胞病理学的敏感性和特异性分别为0.826和1.000。对突变谱的进一步分析表明,携带突变的患者眼内白细胞介素-10水平往往较高(P=0.030),CARD11突变与眼部发病时年龄较小相关(P=0.039),颅内受累患者基因中的多位点突变更多(P=0.013)。
改进后的cfDNA测序流程在有限量的玻璃体液中具有良好的可行性。基于突变的逻辑模型有助于为VRL诊断提供可靠线索。